PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical and Shawn Gibbs, J.D. as Head of Legal
BURLINGTON, Mass.--(BUSINESS WIRE)--Apr 23, 2024--
Source: eagletribune.com
Optimer Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Optimer Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Optimer Pharmaceuticals Today - Breaking & Trending Today
Immix Biopharma Subsidiary Nexcella Appoints Henry McKinnell, Jr., former Chairman and CEO of Pfizer Inc., to Board of Directors
LOS ANGELES - Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. , today announced that effective today, Henry A. McKinnell, Jr, Ph.D., former Chairman and Chief Executive Officer of Pfizer Inc.,... | June 13, 2023
Source: marketscreener.com
Immix Biopharma Subsidiary Nexcella Appoints Henry McKinnell, Jr., former Chairman & CEO of Pfizer Inc., to Board of Directors
Dr. McKinnell joins the Nexcella, Inc. Board of Directors with 35 years of experience at Pfizer, Inc., including 6 years as Chairman and Chief Executive OfficerDr. McKinnell is a former... | June 12, 2023
Source: marketscreener.com
Amaran Biotech Introduces New Vanrx Fully-Automated Robotic Aseptic Filling Line
Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling...
Source: pharmaceuticalonline.com
Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31
HSINCHU, July 13, 2022 /PRNewswire/ -- Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first in Taiwan, has been completed. The new facility minimizes the risks of human factors affecting the quality of the pharmaceutical products, and substantially enhances their safety. The project is now entering the final process validation phase of the medium fill procedures. The new offering reinforces Amaran Biotech's recognition as a leading CDMO (contract development & m...
Source: philippinetimes.com